TFAP2E and esophageal squamous cell carcinoma: The comparison of aberrant mutations (C→A) as well as the methylation changes of TFAP2E in esophageal squamous cell carcinoma (ESCC) and the nearby healthy esophageal mucosal cells of Taiwanese ESCC patients may possibly be indicative of esophageal cancer risks [109].